Teaser text

The Surveillance Evaluation and Research Program within Kirby Institute are world leaders in translational infectious disease research across the Asia-Pacific. With expertise in basic science, clinical and behavioural research, population-health, health economics and systems, modelling, biostatistics and epidemiology, this program conduct collaborative research to provide integrated health care solutions for all.

Body Text

Competitive advantage

  • Extensive experience in clinical trials, diagnostic and implementation research
  • Established clinical and surveillance networks across the Asia-Pacific
  • Integrated framework for effective transdisciplinary infectious disease research
  • Trusted and collaborative partnerships with community, decision makers, industry, academic, not-for-profit organisations, regulatory bodies, government and ministries of health
  • Well characterised cohorts and linked data to model the scale, health-economic impact and real-world market potential of new biomedical technologies


  • Sustainable scale-up of novel behavioural and biomedical interventions strategies
  • Transformational improvements in health outcomes of affected communities globally

Successful outcomes

  • Demonstration of impact of novel point-of-care diagnostic technologies for infections including chlamydia, gonorrhoea, human papilloma virus, hepatitis C virus and HIV infection among remote and marginalised communities

Capabilities and facilities

  • Transdisciplinary field research
  • Rapid and sustainable integration of biomedical interventions into health systems
  • Field evaluation and implementat